Clinical OMICs - Volume 2, Issue 4 - (Page 3)

Molecular Diagnostics in Personalized Medicine Before genomics, the landscape of actionable genetic information was a bleak, arid plain. Now, it's a dense jungle. To find your way around, data analysis must be your guide. EPIGENETIC DRIVERS OF SOMATIC MUTATIONS IN CANCER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Recent research shows that many of the carcinogenic mutations that are found in offspring are not derived from either parent. CLINICAL ACTIONABILITY IN GENOMIC MEDICINE . . . . . . . . . . . . . . . . . . . . . . . .13 Tackling the glut of data will be the key challenge. NGS PROPELS PERSONALIZED ONCOLOGY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .16 Aware that genomic profiling can recognize cancer signatures, oncology establishment stakeholders are converging on new treatment paradigms. Regular Features INNOVATOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .22 Blood Can Replace Tissue Biopsies Cynvenio Biosystems' diagnostic platform analyzes cDNA, captures cancer's dynamism. NEWS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 NEW PRODUCTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11 Cover: Vitanovski / iStockphoto Above bottom: Isak55 / Shutterstock www.clinicalomics.com MEETING ROUNDUP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .28 April 2015 Clinical OMICs 3 https://twitter.com/ClinicalOMICs https://www.youtube.com/channel/UCXBPPWZv--Ne4NfAUHcc8hg http://www.clinicalomics.com

Table of Contents for the Digital Edition of Clinical OMICs - Volume 2, Issue 4

Contents

Clinical OMICs - Volume 2, Issue 4